Back to News
Market Impact: 0.65

Berkshire Hathaway to buy Occidental's OxyChem for $9.7 billion, in Buffett's biggest deal in three years

OXYY
M&A & RestructuringCompany FundamentalsCapital Returns (Dividends / Buybacks)Commodities & Raw MaterialsManagement & GovernanceCredit & Bond Markets
Berkshire Hathaway to buy Occidental's OxyChem for $9.7 billion, in Buffett's biggest deal in three years

Berkshire Hathaway is acquiring Occidental Petroleum's OxyChem unit for $9.7 billion in cash, marking its largest deal since 2022 and deploying a portion of its substantial $344 billion cash reserves. Occidental plans to use $6.5 billion of the proceeds to pay down debt, a strategic move expected to enable the resumption of stock buybacks and complete its long-term transformation, which prompted a 1.4% premarket increase in its shares. This acquisition further expands Berkshire's chemical sector holdings and its existing significant stake in Occidental.

Analysis

Berkshire Hathaway is executing a significant capital deployment by acquiring Occidental Petroleum's OxyChem unit for $9.7 billion in cash, marking its largest transaction since 2022 and utilizing a fraction of its near-record $344 billion cash position. This deal deepens Berkshire's existing involvement with Occidental, in which it holds a 28.2% stake. For Occidental, the transaction is a pivotal deleveraging event, with the company earmarking $6.5 billion of the proceeds to reduce its debt. According to CEO Vicki Hollub, this balance sheet reinforcement is the final step in a decade-long transformation, intended to "unlock" shareholder value and, critically, enable the resumption of its share repurchase program. The market's positive reception was evidenced by a 1.4% premarket rise in Occidental's shares. The deal also carries a strong endorsement from Berkshire's leadership, with incoming CEO Greg Abel highlighting the move as a demonstration of Occidental's commitment to long-term financial stability, providing a layer of validation for the transaction's strategic merit.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo